ClinicalTrialsFinder

Metastatic Prostate Cancer (mCRPC) Clinical Trials in Kobe

1 recruitingKobe, Japan

Showing 1–1 of 1 trials

Recruiting
Phase 1

A Phase I Study of JSB462 (Luxdegalutamide) in Japanese Patients With Metastatic Prostate Cancer

Metastatic Prostate Cancer (mCRPC)
Novartis Pharmaceuticals15 enrolled4 locationsNCT07174063